Hepatect CP 50 IU/ml; solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

hepatect cp 50 iu/ml; solution for infusion

biotest pharma gmbh - human plasma protein; hbs antibodies - solution for infusion - 50 international unit(s)/millilitre - specific immunoglobulins; hepatitis b immunoglobulin

HEPATECT CP SOLUTION FOR INFUSION 50 IUML Singapore - English - HSA (Health Sciences Authority)

hepatect cp solution for infusion 50 iuml

grifols asia pacific pte. ltd. - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - infusion, solution - 50 iu/ml - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 50 iu/ml

ZUTECTRA SOLUTION FOR INJECTION 500 IUML Singapore - English - HSA (Health Sciences Authority)

zutectra solution for injection 500 iuml

eshcol pharmaceutical group singapore pte ltd - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) - injection - 500 iu/ml - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) 500 iu/ml

Niuliva Solution For Infusion 250 I.U.ml Singapore - English - HSA (Health Sciences Authority)

niuliva solution for infusion 250 i.u.ml

grifols asia pacific pte. ltd. - human antihepatitis b immunoglobulin - injection, solution - 250 i.u./ml - human antihepatitis b immunoglobulin 250 i.u./ml

MEGALOTECT CP SOLUTION FOR INFUSION 100 UML Singapore - English - HSA (Health Sciences Authority)

megalotect cp solution for infusion 100 uml

grifols asia pacific pte. ltd. - human cytomegalovirus immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - injection - 100 u/ml - human cytomegalovirus immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 100 u/ml

ZUTECTRA Israel - English - Ministry of Health

zutectra

kamada ltd, israel - human hepatitis b immunoglobulin - solution for injection - human hepatitis b immunoglobulin 500 iu - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b virus (hbv) re-infection in hbsag and hbv-dna negative adult patients at least one week after liver transplantation for hepatitis b induced liver failure.hbv-dna negative status should be confirmed within the last 3 months prior to olt. patients should be hbsag negative before treatment start.the concomitant use of adequate virostatic agents should be considered as standard of hepatitis b re-infection prophylaxis.

HyperHEP B Pre-filled Syringe 0.5mL Singapore - English - HSA (Health Sciences Authority)

hyperhep b pre-filled syringe 0.5ml

grifols asia pacific pte. ltd. - hepatitis b immune globulin (human) - injection - 15-18% - hepatitis b immune globulin (human) 15-18%

HyperHEP B Pre-filled Syringe 1mL Singapore - English - HSA (Health Sciences Authority)

hyperhep b pre-filled syringe 1ml

grifols asia pacific pte. ltd. - hepatitis b immune globulin (human) - injection - 15-18% - hepatitis b immune globulin (human) 15-18%